BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21821433)

  • 1. Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema.
    Tanash HA; Riise GC; Hansson L; Nilsson PM; Piitulainen E
    J Heart Lung Transplant; 2011 Dec; 30(12):1342-7. PubMed ID: 21821433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit.
    Stavem K; Bjørtuft Ø; Borgan Ø; Geiran O; Boe J
    J Heart Lung Transplant; 2006 Jan; 25(1):75-84. PubMed ID: 16399534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
    Bernspång E; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
    Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
    Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Transplantation in Alpha-1-Antitrypsin Deficiency.
    Stone HM; Edgar RG; Thompson RD; Stockley RA
    COPD; 2016; 13(2):146-52. PubMed ID: 26488418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency.
    Tutic M; Bloch KE; Lardinois D; Brack T; Russi EW; Weder W
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):408-13. PubMed ID: 15354100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-lung transplantation: does side matter?
    Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical therapy for chronic obstructive pulmonary disease.
    Martinez FJ; Chang A
    Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
    Bernspång E; Carlson J; Piitulainen E
    Scand J Gastroenterol; 2009; 44(11):1349-55. PubMed ID: 19891586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung transplantation for chronic obstructive pulmonary disease at St Vincent's Hospital.
    Güneş A; Aboyoun CL; Morton JM; Plit M; Malouf MA; Glanville AR
    Intern Med J; 2006 Jan; 36(1):5-11. PubMed ID: 16409307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation.
    Tutic M; Lardinois D; Imfeld S; Korom S; Boehler A; Speich R; Bloch KE; Russi EW; Weder W
    Ann Thorac Surg; 2006 Jul; 82(1):208-13; discussion 213. PubMed ID: 16798216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
    Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of lung transplantation for chronic obstructive pulmonary disease in Sweden.
    Tanash HA; Riise GC; Ekström MP; Hansson L; Piitulainen E
    Ann Thorac Surg; 2014 Dec; 98(6):1930-5. PubMed ID: 25443001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
    Piitulainen E; Tanash HA
    COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful lung transplantation following lung volume reduction surgery.
    Shitrit D; Fink G; Sahar G; Eidelman L; Saute M; Kramer MR
    Thorac Cardiovasc Surg; 2003 Oct; 51(5):274-6. PubMed ID: 14571344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation.
    Meyers BF; Yusen RD; Guthrie TJ; Davis G; Pohl MS; Lefrak SS; Patterson GA; Cooper JD
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):10-7. PubMed ID: 11436031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
    Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.